EMA to Juggle Brexit and New Quality and Safety Guidelines Next Year

Drug GMP Report
A A
In 2018, the European Medicines Agency’s quality and safety working groups intend to tackle several new guidelines, covering the sterilization of products and containers, risk-based prevention of cross contamination in manufacturing and requirements for products containing a device delivery component.

To View This Article:

Login

Subscribe To Drug GMP Report